We are now accepting applications via the ASPET Awards Portal for best presentation and travel awards to EB 2016.
Help the Society bring in new members! Participate in our Member-Get-A-Member program and win prizes!
Check out this special section of Drug Metabolism and Disposition, which is freely available to all through November 30.
Join us for an EB2016 post-meeting colloquium on Drug Discovery in Academia: Recent Successes and Emerging Opportunities
We are very excited to showcase our new website for the 2016 ASPET Annual Meeting. Visit the microsite to access information on the meeting program, abstracts, awards, and more!
The September 2015 issue of The Pharmacologist is now available! Enjoy reading the latest issue in a flipbook format compatible with all your mobile devices.
Forgot your USERNAME OR PASSWORD?
Find us on the popular social networks
Registration to the one-day post EB meeting Drug Discovery Colloquium is now open! Click here for more information or register directly through ASPET.
Take a look at what's happening at ASPET. View the current edition of our eNewsletter.
The September 2015 issue (Volume 57, Issue 3) of the The Pharmacologist is now available! The new issue features a story on the sleepy sickness, Oliver Sacks, and the early days of L-Dopa. Also in this issue, take a look at the EB2016 meeting highlights, a review of the 2015 AAMC-CFAS meeting, an update on the first cycle of our BIG IDEAS initiative, and results of the postdoctoral survey suggesting strategies for supporting young scientists.To download a PDF copy of the September issue, first click on the "share" icon below the flipbook and then choose "download" from the menu options.
Main Line Health has named Charles Antzelevitch, PhD, FACC, FAHA, FHRS, executive director of the cardiovascular research program at Lankenau Institute for Medical Research and director of research at Lankenau Heart Institute.
Read through our
archive of past news and access links to previous eNewsletters, member news, science policy updates, and more.
This week the House and Senate passed a continuing resolution (CR) that will fund federal government agencies through December 11th and the President signed the bill into law before midnight, averting a government shutdown.
The Alliance for a Stronger FDA has issued a statement praising the newly released FDA Science Board Report titled, “Mission Possible: How FDA Can Move at the Speed of Science”, asserting that the report reinforces the need for additional resources.
NIH Director Dr. Francis Collins announced this week the selection of Michael S. Lauer, MD, as the new Deputy Director for Extramural Research.
FASEB kicked off an autumn advocacy campaign this month to encourage lawmakers to increase funding for research in the United States.
This week the National Academies released a report that details the expansion of the federal regulatory system and asserts that the current regulatory framework is negatively impacting the effectiveness of the US research investment by allowing administrative requirements to take time away from research.
©The American Society for Pharmacology and Experimental Therapeutics (ASPET)9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.